(Q46632836)

23 December 2017

title

Dopamine D2 and D3 receptor agonists limit oligodendrocyte injury caused by glutamate oxidative stress and oxygen/glucose deprivation (English)

1 reference

23 December 2017

0 references

4

1 reference

23 December 2017

author name string

Claudia Rosin

1

1 reference

23 December 2017

Sergio Colombo

2

1 reference

23 December 2017

Andrew A Calver

3

1 reference

23 December 2017

Stephen D Skaper

5

1 reference

23 December 2017

publication date

1 December 2005

1 reference

23 December 2017

published in

Glia

1 reference

23 December 2017

volume

52

1 reference

23 December 2017

issue

4

1 reference

23 December 2017

page(s)

336-343

1 reference

23 December 2017

Dopamine-induced protection of striatal neurons against kainate receptor-mediated glutamate cytotoxicity in vitro

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Fused aminotetralins: novel antagonists with high selectivity for the dopamine D3 receptor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Heterocyclic analogues of 2-aminotetralins with high affinity and selectivity for the dopamine D3 receptor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Bicyclic and tricyclic ergoline partial structures. Rigid 3-(2-aminoethyl)pyrroles and 3- and 4-(2-aminoethyl)pyrazoles as dopamine agonists

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Identification of the dopamine D3 receptor in oligodendrocyte precursors: potential role in regulating differentiation and myelin formation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Neuroprotective role of dopamine against hippocampal cell death

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Glutamate neurotoxicity and diseases of the nervous system

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Antagonism of the discriminative stimulus effects of cocaine at two training doses by dopamine D2-like receptor antagonists.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Calcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Obtention and characterization of primary astrocyte and microglial cultures from adult monkey brains.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Postnatal localization and morphogenesis of cells expressing the dopaminergic D2 receptor gene in rat brain: expression in non-neuronal cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Multiple receptors for dopamine

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Bromocriptine protects against delayed neuronal death of hippocampal neurons following cerebral ischemia in the gerbil

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

The link between excitotoxic oligodendroglial death and demyelinating diseases

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Dopamine receptors: from structure to function

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Neurotoxic and neuroprotective actions of catecholamines in cortical neurons

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Human D2 and D4 dopamine receptors couple through betagamma G-protein subunits to inwardly rectifying K+ channels (GIRK1) in a Xenopus oocyte expression system: selective antagonism by L-741,626 and L-745,870 respectively.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Excitatory amino acid induced oligodendrocyte cell death in vitro: receptor-dependent and -independent mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Free radical scavenging properties of apomorphine enantiomers and dopamine: possible implication in their mechanism of action in parkinsonism

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

AMPA and kainate receptors each mediate excitotoxicity in oligodendroglial cultures

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Oxidative glutamate toxicity can be a component of the excitotoxicity cascade.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Neuroprotective effects of the dopamine agonists pramipexole and bromocriptine in 3-acetylpyridine-treated rats.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

News on glutamate receptors in glial cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Resolution and absolute configuration of an ergoline-related dopamine agonist, trans-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H(or 2H)-pyrazolo[3,4-g]quinoline

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Oligodendrocyte degeneration in AD.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Antioxidant properties of bromocriptine, a dopamine agonist.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20250

7 January 2021

Identifiers

DOI

10.1002/GLIA.20250

1 reference

23 December 2017

1 reference

23 December 2017